http://www.in-pharmatechnologist.com/ Breaking News on Pharmaceutical Technology en-gb ℗ & © 2009 Decision News Media fabien.scantamburlo@decisionnews.com (Fabien Scantamburlo) fabien.scantamburlo@decisionnews.com (Fabien Scantamburlo) Sat, 04 Jul 2009 15:06:40 +0200 eZ Components Feed 1.1 (http://ezcomponents.org/docs/tutorials/Feed) http://www.rssboard.org/rss-specification 60 http://www.in-pharmatechnologist.com/var/plain_site/storage/images/rss-feeds/in-pharmatechnologist-rss/1263895-4-eng-GB/in-PharmaTechnologist-RSS.gif http://www.in-pharmatechnologist.com/ http://www.in-pharmatechnologist.com/Industry-Drivers/Pfizer-abandons-Ph-III-Sutent-colon-cancer-study <div class="introduction"> <p> </p> <p> Pfizer has pulled the plug on a Phase III trial of its drug Sutent (sunitinib) in colon cancer after it failed to demonstrate improved clinical efficacy over standard chemotherapy. </p> </div> gareth.macdonald@decisionnews.com Industry Drivers http://www.in-pharmatechnologist.com/Industry-Drivers/Pfizer-abandons-Ph-III-Sutent-colon-cancer-study Thu, 02 Jul 2009 11:00:00 +0200 http://www.in-pharmatechnologist.com/Industry-Drivers/Pharma-people-on-the-move8 <div class="introduction"> <p> </p> <p> in-PharmaTechnologist presents its latest round up of appointments in the pharmaceutical sector, including the new president of Sanofi-Aventis France. </p> </div> nick.taylor@decisionnews.com Industry Drivers http://www.in-pharmatechnologist.com/Industry-Drivers/Pharma-people-on-the-move8 Thu, 02 Jul 2009 11:00:00 +0200 http://www.in-pharmatechnologist.com/Materials-Formulation/Dow-to-shut-3-US-ethylene-plants <div class="introduction"> <p> </p> <p> Dow Chemical is closing three US manufacturing plants, including an ethylene production unit in Hahnville, Louisiana in a further bid to expand its specialty chemicals business. </p> </div> nick.taylor@decisionnews.com Materials & Formulation http://www.in-pharmatechnologist.com/Materials-Formulation/Dow-to-shut-3-US-ethylene-plants Thu, 02 Jul 2009 11:00:00 +0200 http://www.in-pharmatechnologist.com/Materials-Formulation/Spain-to-build-its-first-vaccine-plant <div class="introduction"> <p> </p> <p> The Spanish Ministry of Health is leading a €60m ($84.9m) programme that will build the country’s first vaccine production facility and use Novavax’s recombinant virus-like-particle (VLP) technology. </p> </div> nick.taylor@decisionnews.com Materials & Formulation http://www.in-pharmatechnologist.com/Materials-Formulation/Spain-to-build-its-first-vaccine-plant Thu, 02 Jul 2009 11:00:00 +0200 http://www.in-pharmatechnologist.com/Industry-Drivers/Lantus-cancer-link-research-flawed-says-Sanofi-mulls-R-D-restructuring <div class="introduction"> <p> </p> <p> Sanofi-Aventis has moved to defend its long-acting diabetes treatment Lantus (insulin glargine) and says that recent research linking it to the development of cancer is of “<i>poor quality</i>.” </p> </div> gareth.macdonald@decisionnews.com Industry Drivers http://www.in-pharmatechnologist.com/Industry-Drivers/Lantus-cancer-link-research-flawed-says-Sanofi-mulls-R-D-restructuring Wed, 01 Jul 2009 11:00:00 +0200 http://www.in-pharmatechnologist.com/Materials-Formulation/Rottapharm-expanding-Irish-operations <div class="introduction"> <p> </p> <p> Rottapharm is investing €7m ($9.8m) in its Irish manufacturing operations, which will create 35 jobs and add 2000 sq m housing three manufacturing and associated packaging lines. </p> </div> nick.taylor@decisionnews.com Materials & Formulation http://www.in-pharmatechnologist.com/Materials-Formulation/Rottapharm-expanding-Irish-operations Wed, 01 Jul 2009 11:00:00 +0200 http://www.in-pharmatechnologist.com/Processing-QC/TFS-and-Siemens-hope-to-have-process-analysis-down-PAT <div class="introduction"> <p> </p> <p> US group Thermo Fisher Scientific and industrial engineering giant Siemens have teamed up to offer the pharmaceutical industry a new way of assessing processes used during early drug development, manufacturing scale up and commercial production. </p> </div> gareth.macdonald@decisionnews.com Processing & QC http://www.in-pharmatechnologist.com/Processing-QC/TFS-and-Siemens-hope-to-have-process-analysis-down-PAT Wed, 01 Jul 2009 11:00:00 +0200 http://www.in-pharmatechnologist.com/Processing-QC/PSI-collaborates-with-Microfluidics <div class="introduction"> <p> </p> <p> Particle Sciences (PSI) is aiming to advance its contract processing offering by collaborating with Microfluidics and sharing formulation and nanotechnology expertise. </p> </div> nick.taylor@decisionnews.com Processing & QC http://www.in-pharmatechnologist.com/Processing-QC/PSI-collaborates-with-Microfluidics Wed, 01 Jul 2009 11:00:00 +0200 http://www.in-pharmatechnologist.com/Industry-Drivers/Mylan-partners-to-create-FOBs <div class="introduction"> <p> </p> <p> Mylan has followed Teva’s lead by partnering to develop follow-on biologics (FOB), with the Indian generic maker regarding Biocon as the “<i>ideal partner</i>” to help it enter the market. </p> </div> nick.taylor@decisionnews.com Industry Drivers http://www.in-pharmatechnologist.com/Industry-Drivers/Mylan-partners-to-create-FOBs Tue, 30 Jun 2009 11:00:00 +0200 http://www.in-pharmatechnologist.com/Materials-Formulation/TFC-forms-JV-to-boost-DMSO-output <div class="introduction"> <p> </p> <p> Rising demand in China has led to Toray Fine Chemicals (TFC) establishing a joint venture to produce dimethylsulfoxide (DMSO), a reaction solvent in pharma production. </p> </div> nick.taylor@decisionnews.com Materials & Formulation http://www.in-pharmatechnologist.com/Materials-Formulation/TFC-forms-JV-to-boost-DMSO-output Tue, 30 Jun 2009 11:00:00 +0200